Axelsson B, Ohlsén H
Acta Radiol Oncol Radiat Phys Biol. 1979;18(5):470-80. doi: 10.3109/02841867909128233.
A 'low-dose technique' of obstetric pelvimetry, using rare-earth screens and a reduced ambition level of image quality, yields an estimated absorbed dose to the maternal and foetal gonads of 0.9 and 0.01 mGy, respectively. The resulting risk for 'hereditary ill health' and the risk for induction of leukemia from the absorbed dose to the foetal red bone marrow, have been calculated to be at a very low level.
一种产科骨盆测量的“低剂量技术”,使用稀土增感屏并降低图像质量要求,估计母体和胎儿性腺所接受的吸收剂量分别为0.9和0.01毫戈瑞。由此产生的“遗传疾病”风险以及胎儿红骨髓吸收剂量引发白血病的风险,经计算都处于非常低的水平。